Since President Richard M. Nixon declared a war on cancer more than 30 years ago, the battle still rages on several fronts.
Exploring Links Between Smoking, Diet, and Oral Cancer Risk: What Should Be Message to Patients?
According to the American Cancer Society, smokers are six times more likely than nonsmokers to develop oral cavity and oropharyngeal cancers.
New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer
A Swing of the Pendulum?
For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.
Case Studies: Malpractice or Bad Outcome?
A Practical Protocol: Identifying Thyroidectomy Patients at Low Risk for Significant Hypocalcemia
Researchers from Johns Hopkins School of Medicine have identified a means of detecting thyroidectomy patients who can safely be discharged early after surgery, with little risk of developing significant hypocalcemia.
Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
Recurrent respiratory papillomatosis (RRP) remains a devastating disease for pediatric patients.